ADN 0.00% 1.6¢ andromeda metals limited

General comments/chat, page-37883

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    Thanks for the suggestion however cancer is a very complex disease. There are hundreds of types/subtypes and the patient’s cancer needs to be an optimal match for the treatment used for any chance of success.

    After failing two forms of immunotherapy I have had a sample of my cancer screened against 42 drugs in the US. It responded to 26 of them so I have lots of chemo options identified from this with a varying probability of working. Two of the drug responses were exceptional so one of these is the first chemo option I will try.

    Due to an immunotherapy treatment I failed on trial and also surgery there are fewer and fewer trials I would be eligible for anyway. My tumour response on that trial was mixed CR/PR for some tumours, however my cancer eventually progressed.
    Last edited by wombat777: 29/03/23
 
watchlist Created with Sketch. Add ADN (ASX) to my watchlist
(20min delay)
Last
1.6¢
Change
0.000(0.00%)
Mkt cap ! $49.76M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 100000 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 3000000 2
View Market Depth
Last trade - 16.12pm 19/08/2024 (20 minute delay) ?
ADN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.